You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 71 No. 5, May 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics

III. Changes in Visual Function and Pupil Size During Topical Dexamethasone Application

MANSOUR F. ARMALY, MD

Arch Ophthalmol. 1964;71(5):636-644.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The clinical significance of the ocular hypertension induced by topical steroid application is ultimately dependent upon the nature and magnitude of its effect on visual function. It has been shown in preceding publications that the effect of dexamethasone on aqueous humor dynamics was reversible in nature1,2; complete recovery of the pretreatment values of intraocular pressure and outflow facility was achieved one to two weeks after the cessation of dexamethasone application in all the cases studied. It should be pointed out, in this respect, that the duration of dexamethasone application in these studies did not exceed, in general, four to five weeks. The possibility that longer duration of drug application and of hypertension might result in a permanent change in outflow facility has not been definitively ruled out.

The relationship between intraocular pressure level and visual field damage is not a simple one. The involved variables and their relative contribution . . . [Full Text PDF of this Article]


Author Affiliations

lowa City

From the Department of Ophthalmology, State University of Iowa, and the University Hospitals.


Footnotes

Submitted for publication Oct 21, 1963.

This investigation was supported in part by research grant NB-02423 and grant NB-03636 from the National Institute of Neurological Diseases and Blindness, United States Public Health Service, Bethesda, Md.

Dexamethasone 21-phosphate (Decadron phosphate), Merck Sharp & Dohme.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.